Novel GMO-Based Vaccines against Tuberculosis: State of the Art and Biosafety Considerations

Novel efficient vaccines are needed to control tuberculosis (TB), a major cause of morbidity and mortality worldwide. Several TB vaccine candidates are currently in clinical and preclinical development. They fall into two categories, the one of candidates designed as a replacement of the Bacille Cal...

Descripción completa

Detalles Bibliográficos
Autores principales: Leunda, Amaya, Baldo, Aline, Goossens, Martine, Huygen, Kris, Herman, Philippe, Romano, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494264/
https://www.ncbi.nlm.nih.gov/pubmed/26344627
http://dx.doi.org/10.3390/vaccines2020463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494264/
https://www.ncbi.nlm.nih.gov/pubmed/26344627
http://dx.doi.org/10.3390/vaccines2020463

Ejemplares similares